Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Disease, Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06863831
What this trial is testing

Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 536
Large-scale testing (Phase 3)Study completedNCT02633202
What this trial is testing

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 338
Testing effectiveness (Phase 2)Study completedNCT04895345
What this trial is testing

TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 25
Not applicableStudy completedNCT00571077
What this trial is testing

Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study

Who this might be right for
Thyroid NeoplasmsThyroid Nodules
Hadassah Medical Organization 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05784012
What this trial is testing

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 34
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Early research (Phase 1)Study completedNCT00967577
What this trial is testing

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Who this might be right for
Kidney CancerHead and Neck CancerBreast Cancer+6 more
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Study completedNCT01213030
What this trial is testing

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer
Siemens Molecular Imaging 12
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Testing effectiveness (Phase 2)Study completedNCT05694819
What this trial is testing

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Who this might be right for
Salivary Gland Cancer
National Cancer Center Hospital East 57
Not applicableLooking for participantsNCT06524167
What this trial is testing

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 80
Not applicableLooking for participantsNCT06275737
What this trial is testing

POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric

Who this might be right for
Pancreatic Ductal AdenocarcinomaEsophageal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 72
Not applicableEnrolling By InvitationNCT07642401
What this trial is testing

Large-scale Models of Esophageal Cancer and Related Research

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 12,000
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)Study completedNCT03416153
What this trial is testing

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
University of Michigan Rogel Cancer Center 91
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Ended earlyNCT00551759
What this trial is testing

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 22
Next Page